HSS Journal ®

, Volume 8, Issue 2, pp 159–164

Pharmacologic Management of Osteoarthritis-Related Pain in Older Adults

A Review Shows that Many Drug Therapies Provide Small-to-Modest Pain Relief
  • M. Carrington Reid
  • Rouzi Shengelia
  • Samantha J. Parker
State of the Science


Because pain is a common and debilitating symptom of osteoarthritis in older adults, the authors reviewed data on the efficacy and safety of commonly used oral, topical, and intraarticular drug therapies in this population. A search of several databases found that most studies have focused on knee osteoarthritis and reported only short-term outcomes. Also, treatment efficacy was found to vary by drug class; the smallest effect was observed with acetaminophen and the largest with opioids and viscosupplements. Acetaminophen and topical agents had the best safety profiles, whereas oral nonsteroidal antiinflammatory drugs and opioids had the worst. Little data were available on patients ages 75 years old and older and on patients from diverse racial and ethnic groups. Most drug therapies gave mild-to-moderate pain relief; their long-term safety and efficacy and their effects in diverse populations (particularly older adults) remain undetermined.


Analgesia older adults osteoarthritis pain 


  1. 1.
    Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults—United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50(7):120–5.Google Scholar
  2. 2.
    Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2003–2005. MMWR Morb Mortal Wkly Rep 2006;55(40):1089–92.Google Scholar
  3. 3.
    Dillon CF, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991–94. J Rheumatol 2006;33(11):2271–9.PubMedGoogle Scholar
  4. 4.
    Qvist P, et al. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? Pharmacol Res 2008; 58(1):1–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Sarzi-Puttini P, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005;35(1 Suppl 1):1–10.PubMedCrossRefGoogle Scholar
  6. 6.
    American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43(9): 1905–15.Google Scholar
  7. 7.
    Austrian JS, et al. Perceived barriers to trying self-management approaches for chronic pain in older persons. J Am Geriatr Soc 2005;53(5):856–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Sarzi-Puttini P, et al. Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience. Semin Arthritis Rheum 2005;35(1 Suppl 1):38–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Barry LC, et al. Identification of pain-reduction strategies used by community-dwelling older persons. J Gerontol A Biol Sci Med Sci 2005;60(12):1569–75. PubMedCrossRefGoogle Scholar
  10. 10.
    Jordan KM, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62(12):1145–55.PubMedCrossRefGoogle Scholar
  11. 11.
    Ibrahim SA. Racial variations in the utilization of knee and hip joint replacement: an introduction and review of the most recent literature. Curr Orthop Pract 2010;21(2): 126–31.PubMedCrossRefGoogle Scholar
  12. 12.
    AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(6 Suppl):S205-S224.Google Scholar
  13. 13.
    AGS Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57(8): 1331–46.CrossRefGoogle Scholar
  14. 14.
    Leveille SG, et al. Disabling symptoms: what do older women report? J Gen Intern Med 2002;17(10):766–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Reid MC, et al. Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med 2011;12(9):1336–57.PubMedCrossRefGoogle Scholar
  16. 16.
    Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.; 1988.Google Scholar
  17. 17.
    Towheed TE, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006(1):CD004257.Google Scholar
  18. 18.
    Zhang W, et al. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004;63(8):901–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Larson AM, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6):1364–72.PubMedCrossRefGoogle Scholar
  20. 20.
    Rahme E, et al. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008;103(4):872–82.PubMedCrossRefGoogle Scholar
  21. 21.
    U.S. Food and Drug Administration. Drugs: acetaminophen information 2011. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107.htm. Accessed 1 July 2011.
  22. 22.
    Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001;120(3): 594–606.PubMedCrossRefGoogle Scholar
  23. 23.
    Talley NJ, et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995;40(6):1345–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Bjordal JM, et al. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004;329(7478):1317.PubMedCrossRefGoogle Scholar
  25. 25.
    Trelle S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342:c7086.PubMedCrossRefGoogle Scholar
  26. 26.
    Perez Gutthann S, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996;156(21):2433–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Wolfe MM, et al. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340(24): 1888–99.PubMedCrossRefGoogle Scholar
  28. 28.
    Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000;160(6):777–84.PubMedCrossRefGoogle Scholar
  29. 29.
    Nüesch E, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009(4):CD003115.Google Scholar
  30. 30.
    Papaleontiou M, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2010;58(7):1353–69.PubMedCrossRefGoogle Scholar
  31. 31.
    Solomon DH, et al. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170(22): 1968–76.PubMedCrossRefGoogle Scholar
  32. 32.
    Spitz A, et al. Primary care providers’ perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr 2011;11:35.PubMedCrossRefGoogle Scholar
  33. 33.
    Towheed TE, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001(1):CD002946.Google Scholar
  34. 34.
    Black C, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 2009;13(52): 1–148.PubMedGoogle Scholar
  35. 35.
    Reichenbach S, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007;146(8): 580–90. PubMedGoogle Scholar
  36. 36.
    Poolsup N, et al. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005;39(6): 1080–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Taylor RS, et al. Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin 2011;27(3): 605–22.PubMedCrossRefGoogle Scholar
  38. 38.
    Haroutiunian S, et al. Topical NSAID therapy for musculoskeletal pain. Pain Med 2010;11(4):535–49.PubMedCrossRefGoogle Scholar
  39. 39.
    Lin J, et al. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329(7461):324.PubMedCrossRefGoogle Scholar
  40. 40.
    Baraf HS, et al. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging 2011;28(1):27–40.PubMedCrossRefGoogle Scholar
  41. 41.
    Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm. Curr Med Res Opin 2010; 26(12):2871–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Makris UE, et al. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol 2010;37(6): 1236–43.PubMedCrossRefGoogle Scholar
  43. 43.
    Kivitz A, et al. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther 2008;30(12):2366–77.PubMedCrossRefGoogle Scholar
  44. 44.
    Galer BS, et al. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin 2004;20(9):1455–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Gammaitoni AR, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin 2004;20 Suppl 2:S13-S19.PubMedCrossRefGoogle Scholar
  46. 46.
    Mason L, et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004;328(7446):991.PubMedCrossRefGoogle Scholar
  47. 47.
    Kosuwon W, et al. Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo. J Med Assoc Thai 2010;93(10):1188–95.PubMedGoogle Scholar
  48. 48.
    Bellamy N, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006(2):CD005328.Google Scholar
  49. 49.
    Heyworth BE, et al. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am 2008;33(1):40–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Atchia I, et al. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis 2011;70(1):110–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Shimizu M, et al. Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid. J Orthop Sci 2010;15(1):51–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Chevalier X, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 2010;69(1):113–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Clarke S, et al. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee 2005;12(1):57–62.PubMedCrossRefGoogle Scholar
  54. 54.
    Bellamy N, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005(2):CD005321.Google Scholar
  55. 55.
    Bourgeois FT, et al. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153(3):158–66.PubMedGoogle Scholar
  56. 56.
    Green CR, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 2003;4(3): 277–94.PubMedCrossRefGoogle Scholar
  57. 57.
    Committee on Advancing Pain Research, Care, and Education, Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press; 2011. http://www.nap.edu/catalog.php?record_id=13172. Accessed 1 July 2011.
  58. 58.
    MUST for Seniors. Medication use safety training for seniors [landing page]. National Council on Patient Information and Education. 2011. http://www.mustforseniors.org. Accessed 1 July 2011.
  59. 59.
    Hall J, et al. Effectiveness of interventions designed to promote patient involvement to enhance safety: a systematic review. Qual Saf Health Care 2010;19(5):e10.PubMedCrossRefGoogle Scholar
  60. 60.
    Paparella SF, et al. Patient safety simulation: learning about safety never seemed more fun. J Nurses Staff Dev 2004; 20(6):247–52.PubMedCrossRefGoogle Scholar

Copyright information

© Hospital for Special Surgery 2012

Authors and Affiliations

  • M. Carrington Reid
    • 1
    • 2
  • Rouzi Shengelia
    • 2
  • Samantha J. Parker
    • 2
    • 3
  1. 1.New York–Presbyterian HospitalNew YorkUSA
  2. 2.Weill Cornell Medical College (WCMC)New YorkUSA
  3. 3.Tulane University School of MedicineNew OrleansUSA

Personalised recommendations